Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
Theravance Biopharma (NASDAQ: TBPH) has announced it will release its fourth quarter and full year 2024 financial results and business update after market close on February 26, 2025. The company will host a conference call and simultaneous webcast at 5:00 pm EST (2:00 pm PST/10:00 pm GMT) on the same day.
Interested participants can pre-register for the telephone conference call through the provided link. The webcast will be accessible through Theravance Biopharma's website under the Investors section, Events and Presentations. A replay of the webcast will remain available on the company's website for 30 days until March 28, 2025.
Theravance Biopharma (NASDAQ: TBPH) ha annunciato che rilascerà i suoi risultati finanziari per il quarto trimestre e l'intero anno 2024 e un aggiornamento aziendale dopo la chiusura del mercato il 26 febbraio 2025. L'azienda ospiterà una conferenza telefonica e un webcast simultaneo alle 17:00 EST (14:00 PST/22:00 GMT) lo stesso giorno.
I partecipanti interessati possono pre-registrarsi per la conferenza telefonica tramite il link fornito. Il webcast sarà accessibile attraverso il sito web di Theravance Biopharma nella sezione Investitori, Eventi e Presentazioni. Una registrazione del webcast rimarrà disponibile sul sito dell'azienda per 30 giorni fino al 28 marzo 2025.
Theravance Biopharma (NASDAQ: TBPH) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 y una actualización empresarial después del cierre del mercado el 26 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica y un webcast simultáneo a las 5:00 pm EST (2:00 pm PST/10:00 pm GMT) el mismo día.
Los participantes interesados pueden pre-registrarse para la conferencia telefónica a través del enlace proporcionado. El webcast será accesible a través del sitio web de Theravance Biopharma en la sección de Inversores, Eventos y Presentaciones. Una grabación del webcast estará disponible en el sitio de la empresa durante 30 días hasta el 28 de marzo de 2025.
Theravance Biopharma (NASDAQ: TBPH)는 2024년 4분기 및 연간 재무 결과 및 사업 업데이트를 2025년 2월 26일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 5:00 EST (오후 2:00 PST/밤 10:00 GMT)에 전화 회의 및 동시 웹캐스트를 진행할 예정입니다.
관심 있는 참가자는 제공된 링크를 통해 전화 회의에 사전 등록할 수 있습니다. 웹캐스트는 Theravance Biopharma의 웹사이트의 투자자 섹션, 이벤트 및 프레젠테이션에서 접근할 수 있습니다. 웹캐스트의 재생은 회사 웹사이트에서 30일 동안, 즉 2025년 3월 28일까지 이용 가능합니다.
Theravance Biopharma (NASDAQ: TBPH) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année 2024 ainsi qu'une mise à jour de l'entreprise après la clôture du marché le 26 février 2025. La société organisera une conférence téléphonique et un webinaire simultané à 17h00 EST (14h00 PST/22h00 GMT) le même jour.
Les participants intéressés peuvent s'inscrire à l'avance pour la conférence téléphonique via le lien fourni. Le webinaire sera accessible via le site Web de Theravance Biopharma dans la section Investisseurs, Événements et Présentations. Un enregistrement du webinaire sera disponible sur le site de l'entreprise pendant 30 jours jusqu'au 28 mars 2025.
Theravance Biopharma (NASDAQ: TBPH) hat bekannt gegeben, dass es seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 sowie ein Unternehmensupdate nach Marktschluss am 26. Februar 2025 veröffentlichen wird. Das Unternehmen wird am selben Tag um 17:00 Uhr EST (14:00 Uhr PST/22:00 Uhr GMT) eine Telefonkonferenz und einen gleichzeitigen Webcast veranstalten.
Interessierte Teilnehmer können sich über den bereitgestellten Link für die Telefonkonferenz vorregistrieren. Der Webcast wird über die Website von Theravance Biopharma im Bereich Investoren, Veranstaltungen und Präsentationen zugänglich sein. Eine Aufzeichnung des Webcasts bleibt 30 Tage lang bis zum 28. März 2025 auf der Website des Unternehmens verfügbar.
- None.
- None.
Conference Call Information
To participate in the live call by telephone, please pre-register here. Those interested in listening to the conference call live via the internet may do so by visiting Theravance Biopharma's website at www.theravance.com, under the Investors section, Events and Presentations.
A replay of the webcast will be available on Theravance Biopharma's website for 30 days through March 28, 2025.
About Theravance Biopharma
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA), has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in MSA patients. The Company is committed to creating/driving shareholder value.
For more information, please visit www.theravance.com.
THERAVANCE BIOPHARMA®, THERAVANCE® and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).
YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing in this press release are the property of their respective owners.
Contact:
investor.relations@theravance.com
650-808-4045
View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-26-2025-302374229.html
SOURCE Theravance Biopharma, Inc.
FAQ
When will Theravance Biopharma (TBPH) report Q4 and full year 2024 earnings?
What time is TBPH's Q4 2024 earnings conference call?
How long will TBPH's Q4 2024 earnings webcast replay be available?
Where can I access TBPH's Q4 2024 earnings webcast?
